Cell Cryopreservation companies

Key Cell Cryopreservation Market Players:

Below is the list of the key players operating in the global cell cryopreservation market:

• Thermo Fisher Scientific Inc (U.S.)
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• Miltenyi Biotec GmbH (Germany)
• BioLife Solutions INC (U.S.)
• PromoCell GmbH (Germany)
• Corning Incorporated (U.S.)
• Cooper Companies (U.S.)
• Bio-Rad Laboratories (India)
• Creative Biolabs (U.S.)
• Lonza (Switzerland)
• HiMedia Laboratories (India)

Key players are accelerating the growth of the cell cryopreservation market by expanding their portfolios of GMP-grade freezing media, advanced controlled-rate freezers, and automated storage systems tailored for cell therapy and biobanking applications. Many companies are investing heavily in R&D to develop serum-free, low-toxicity cryomedia that improve post-thaw viability an essential requirement for cell and gene therapy workflows. Strategic partnerships with biopharmaceutical firms and research institutes are helping major vendors integrate cryopreservation systems into end-to-end cell-processing platforms. Leading manufacturers are also scaling global distribution networks and service capabilities to support rapidly expanding clinical trial and biobanking operations. Collectively, these efforts strengthen supply reliability, enhance product performance, and increase overall adoption across research, clinical, and commercial environments.

Corporate Landscape of the Global Cell Cryopreservation Market

• Thermo Fisher is a leading provider of integrated cryopreservation solutions, offering controlled-rate freezers, cryogenic storage systems, and GMP-grade freezing media widely used in cell therapy, biobanking, and pharmaceutical research. The company’s Gibco CryoSuite and Nalgene cryogenic containers are industry standards for ensuring high post-thaw cell viability. Thermo Fisher also supports large-scale manufacturing through end-to-end cell-processing platforms that incorporate validated cryostorage workflows. Its extensive global distribution and service network enable reliable supply and compliance support for regulated laboratories. Continued investments in automation and digital monitoring technologies further strengthen the company’s role in the cryopreservation market.
• Miltenyi Biotec is a major innovator in cell-processing technologies, offering cryopreservation products designed to maintain the functionality and recovery of delicate cell types, particularly immune and stem cells. Its CryoMACS Freezing Bags and GMP-grade cryomedia are widely used in clinical manufacturing of cell and gene therapies. The company’s integrated CliniMACS platform ties upstream cell isolation and activation with downstream freezing workflows, making Miltenyi a preferred partner for ATMP developers. Miltenyi also operates multiple GMP facilities that support contract manufacturing and clinical research worldwide. Its consistent focus on translational applications positions it as a key driver of cryopreservation adoption in regulated environments.
• BioLife Solutions is a specialist in biopreservation, offering high-performance cryomedia such as CryoStor and HypoThermosol, which are recognized for improving post-thaw survival and stability of therapeutic cell products. The company also provides advanced liquid nitrogen freezers and ultra-cold storage solutions under the SciSafe® and Stirling Ultracold® brands, enabling end-to-end cold-chain continuity. BioLife’s products are widely adopted by cell therapy manufacturers, CDMOs, and biobanks due to their strong regulatory documentation and proven performance across numerous clinical programs. Strategic acquisitions have expanded its footprint in automated storage and cold-chain logistics. Its technologies are central to many commercial and late-stage cell therapy workflows, making it a cornerstone of the cryopreservation market.
• PromoCell provides high-quality primary human cells, culture media, and cryopreserved cell systems used extensively in research and preclinical applications. The company’s cryopreserved primary cells support consistent experimental reproducibility and are widely applied in regenerative medicine, toxicology, and drug discovery workflows. PromoCell also develops specialized freezing media optimized for sensitive human cell types, ensuring high viability after thawing. Its strong focus on standardized, ethically sourced human cell models makes it a valuable supplier for laboratories scaling biobanking and translational research. The company’s European manufacturing base and quality certifications further support adoption in regulated environments.
• Corning is a major supplier of cryogenic vials, storage bottles, cryoboxes, and liquid-nitrogen-compatible accessories essential for cell banking and long-term preservation. Its Corning and Falcon-branded cryovials are widely used across academic, clinical, and industrial laboratories due to their reliability, sterility, and regulatory compliance. Corning also offers advanced cell culture systems, including closed-system vessels, that integrate smoothly with freezing processes for cell therapy manufacturing. Ongoing innovation in materials science enables the company to produce durable, low-contamination storage solutions critical for maintaining sample integrity. As biobanking and GMP manufacturing expand globally, Corning’s broad product range and trusted quality make it a key enabler of cryopreservation workflows.